What is the recommended treatment for allergic rhinitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Allergic Rhinitis

Intranasal corticosteroids are the first-line treatment for allergic rhinitis, as they are the most effective medication class for controlling all nasal symptoms including congestion, rhinorrhea, sneezing, and itching. 1, 2, 3

Treatment Algorithm Based on Severity

Mild Intermittent or Mild Persistent Allergic Rhinitis

  • Start with either a second-generation oral antihistamine (cetirizine, fexofenadine, desloratadine, loratadine) or an intranasal antihistamine (azelastine, olopatadine) as first-line options. 4
  • Second-generation antihistamines are preferred over first-generation agents due to significantly less sedation and fewer anticholinergic effects. 1, 3
  • These agents effectively control sneezing, itching, and rhinorrhea but have limited effect on nasal congestion. 4

Moderate to Severe or Persistent Allergic Rhinitis

  • Begin treatment with an intranasal corticosteroid (fluticasone, triamcinolone, budesonide, mometasone) as monotherapy. 1, 2, 3, 4
  • Intranasal corticosteroids are superior to leukotriene receptor antagonists (montelukast) for allergic rhinitis treatment. 2
  • These medications control all nasal symptoms including congestion, which antihistamines cannot adequately address. 5
  • Clinical efficacy can be demonstrated within 24 hours after the first dose. 6

Escalation for Inadequate Response to Monotherapy

Combination Therapy

  • For moderate to severe allergic rhinitis not responding to intranasal corticosteroid monotherapy, add an intranasal antihistamine (not an oral antihistamine) to the intranasal corticosteroid. 2, 3
  • This combination provides greater symptom reduction than either agent alone. 2, 7
  • Do not add oral antihistamines to intranasal corticosteroids—multiple high-quality trials show no additional benefit. 2, 3
  • Do not add leukotriene receptor antagonists to intranasal corticosteroids—they provide no additional benefit and are less effective than intranasal corticosteroids alone. 3

Adjunctive Therapies

  • Nasal saline irrigation is beneficial as sole therapy or adjunctive treatment for chronic rhinorrhea. 2, 3
  • Intranasal ipratropium bromide effectively reduces rhinorrhea but has no effect on other nasal symptoms; combining it with intranasal corticosteroids is more effective than either alone. 2, 3

Refractory Disease Management

  • Refer patients with inadequate response to pharmacologic therapy for allergen immunotherapy (subcutaneous or sublingual), which is the only disease-modifying treatment. 2, 3
  • Immunotherapy may prevent development of new allergen sensitizations and reduce future asthma risk in patients with allergic rhinitis. 2, 3
  • Benefits can be maintained for years after discontinuation of treatment. 3

Specific Dosing Considerations

Adults and Children ≥12 Years

  • Fluticasone propionate: 1-2 sprays per nostril once daily (FDA-approved for ages ≥4 years). 1, 8
  • Triamcinolone acetonide: 1-2 sprays per nostril once daily. 1
  • Mometasone furoate: 1-2 sprays per nostril once daily. 1
  • Duration: May use up to 6 months of daily use before checking with a doctor. 8

Children Ages 4-11 Years

  • Use lower doses: 1 spray per nostril once daily. 1, 8
  • Triamcinolone acetonide is FDA-approved for children ≥2 years. 1
  • Mometasone furoate is approved for children as young as 2 years. 1
  • Duration limit: Check with a doctor if use exceeds 2 months per year due to potential effects on growth rate. 1, 8

Critical Pitfalls to Avoid

Medications to Avoid

  • Never use first-generation antihistamines due to sedative and anticholinergic effects. 1, 3
  • Avoid topical decongestants for more than 3 days to prevent rhinitis medicamentosa (rebound congestion). 1, 3
  • Do not use oral decongestants in young children as they can cause irritability, insomnia, and loss of appetite. 1
  • Systemic corticosteroids should be reserved only for severe, intractable symptoms unresponsive to other treatments and used only for short courses. 1, 2

Proper Technique

  • Direct the intranasal corticosteroid spray away from the nasal septum to avoid mucosal erosions and potential septal perforations. 3
  • Prime the pump before first use and after periods of non-use to ensure full dosing. 8

Environmental Control

  • Allergen avoidance is fundamental to successful management and should be implemented even in early treatment. 1, 2, 3
  • Identify and educate patients about avoiding specific triggers. 1

Special Considerations

Drug Interactions

  • Avoid concurrent use with ritonavir (HIV medication) or ketoconazole pills, as they may cause excessive fluticasone levels. 8
  • Exercise caution when using other glucocorticosteroid medications concurrently for asthma, skin conditions, or eye conditions. 8

Comorbid Conditions

  • Always assess for associated conditions such as asthma, atopic dermatitis, sleep-disordered breathing, conjunctivitis, rhinosinusitis, and otitis media. 2
  • Treatment of allergic rhinitis with intranasal corticosteroids may improve asthma control in patients with coexisting asthma. 3

References

Guideline

Treatment of Allergic Rhinitis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Atopic Rhinitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rhinitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current therapeutical strategies for allergic rhinitis.

Expert opinion on pharmacotherapy, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.